Lyme Disease Diagnostics Market was valued at around USD 1200 million in 2019 and is expected to post cagr of around 7.5% during the forecast period as per the market report by Value Market Research. The rising prevalence of Lyme disease and its adverse effects on the global population will drive the diagnostic devices market. Rising investments by the government and private sectors to improve healthcare facilities will further stimulate this market's growth. Growing research and development activities and emerging new diagnostic devices will boost the market growth. Surging disposable income and increased awareness about the existing diagnostic tools to test the disease's symptoms will be a market booster.
Lyme disease, a bacterial infection, is characterized by symptoms like fever, headache, fatigue, skin rash, and is spread by infected black-legged ticks. The most used diagnostic devices for this disease are based on the principle of testing the antibody biomarkers in a patients' blood. The various tests carried out by these devices include serological tests like ELISA, western blot, and PCR, urine antigen tests, immunofluorescent tests, etc. New point-of-care microfluidic test devices are being introduced into the diagnostic devices pool for faster and early diagnosis. If left untreated, Lyme disease can cause severe neurological and cardiac complications.
The report “Global Lyme Disease Diagnostics Market Report By Emerging Diagnostic Technology (Serological Test, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, Nucleic Acid Test), By End User (Hospitals, Public/Private Laboratories, Physicians Office) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026" initially provides the market overview, executive summary followed by detailed revenue analysis bifurcated by segments and regions. The study researches the historical trends of the industry along with understanding all the geo-economic conditions related to the lyme disease diagnostics market, thus making the foundation of the report strong and reliable.
On the basis of Emerging Diagnostic Technology the market is segmented into Serological Test, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, Nucleic Acid Test. By End User the lyme disease diagnostics market is categorised as Hospitals, Public/Private Laboratories, Physicians Office.Regionally, the report is segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. In this section of the report the data related to all the segments are analysed as per regions.
The Report Segments Global Lyme Disease Diagnostics Market -
By Emerging Diagnostic Technology
- Serological Test
- Urine Antigen Tests
- Lymphocytic Transformation Test
- Immunofluorescent Staining
- Nucleic Acid Test
By End User
- Hospitals
- Public/Private Laboratories
- Physicians Office
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Players Profiled In the Report:
Abbott Laboratories, T2 Biosystems, Inc., Bio-Rad Laboratories, Inc., Alere Inc., Roche Diagnostics International Ltd., Graphene Frontiers, LLC, Covance Inc., Immunetics Inc., GlaxoSmithKline Pharmaceuticals Ltd., Boulder Diagnostics Inc., Affymetrix Inc., Siemens AG, Baxter International Inc.
Download the FREE SAMPLE of Global Lyme Disease Diagnostics Market Research Report
About Value Market Research -
Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information. Our analysts’ team is well equipped with all research tools and techniques and hold deep knowledge of the industry they are working for.
We ensure intellectual, precise and quality data is delivered to our client. We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.
Contact:
Value Market Research
401/402, TFM, Nagras Road, Aundh, Pune-7.
Maharashtra, INDIA.
Tel: +1-888-294-1147
Email: sales@valuemarketresearch.com
Website: https://www.valuemarketresearch.com